<?xml version="1.0"?><?xml-stylesheet type="text/xsl" href="drug-table.xslt"?><drug name = "diphenhydrAMINE liq ORAL">
<dose><value>2.5</value>
<value>5</value>
<value>10</value>
<value>15</value>
<value>20</value>
<value>50</value>
</dose>
<route><value>PO</value>
</route>
<strength><value>1.25 mg/mL</value>
</strength>
<frequency><value>Q4H</value>
<value>Q6H</value>
<value>ONCE</value>
</frequency>
<instruction><value>DAY 1 of 21. If oral diphenhydrAMINE has not been taken by patient as instructed, administer 60 minutes pre-PACLitaxel. May be administered by IV route.</value>
<value>DAY 1 of 21. PRN. May be administered by IV route.</value>
<value>DAY 1 of 7. If oral diphenhydrAMINE has not been taken by patient as instructed, administer 60 minutes pre-PACLitaxel. May be administered by IV route.</value>
<value>DAY 1 of 7. PRN. May be administered by IV route.</value>
</instruction>
<volume></volume>
<units><value>mL</value>
<value>mg</value>
</units>
<Population><value>Adjuvant PACLitaxel/CARBOplatin. Non-Small Cell Lung Cancer</value>
<value>PACLitaxel / CARBOplatin. Advanced / Metastatic Non-Small Cell Lung Cancer</value>
<value>PACLitaxel/CARBOplatin (Weekly) and concurrent RT. Non-Small Cell Lung Cancer.</value>
</Population>
<IndicationPRN></IndicationPRN>
<AdditionalNotes></AdditionalNotes>
<BackgroundInformation></BackgroundInformation>
<PRNInformation><value>YES</value>
</PRNInformation>
<AHSFormularyStatus></AHSFormularyStatus>
<HighAlert></HighAlert>
</drug>